Suggest biotin containing FDA approved medicines for alopecia
FDA approved biotin containing medicine alopecia hair loss 2024 2025
biotin alopecia treatment FDA approved
biotin supplementation alopecia hair loss evidence
biotin alopecia hair growth clinical trial
PMID: 38688776
FDA approved drugs containing biotin alopecia hair loss supplement prescription 2025
| Drug | Brand | Type | Indication |
|---|---|---|---|
| Minoxidil (topical/oral) | Rogaine, others | Vasodilator / hair cycle promoter | Androgenetic alopecia (men & women) |
| Finasteride | Propecia | 5-alpha reductase inhibitor | Male androgenetic alopecia |
| Baricitinib | Olumiant | JAK inhibitor | Alopecia areata (adults) |
| Ritlecitinib | Litfulo | JAK inhibitor | Alopecia areata (adults & adolescents ≥12 yr) |
| Deuruxolitinib | Leqselvi | JAK inhibitor | Alopecia areata (adults, approved July 2024) |
| Scenario | Role of Biotin |
|---|---|
| Androgenetic alopecia (male/female pattern) | No proven benefit unless deficient |
| Alopecia areata | No FDA role; JAK inhibitors are first-line |
| Biotin deficiency-related alopecia | Biotin supplementation (10 mg/day) is the treatment |
| Valproic acid-induced alopecia | Biotin supplementation may help |
| Isotretinoin-induced telogen effluvium | May help (reduced biotinidase activity mechanism) |
Important note: High-dose biotin supplements can interfere with thyroid function tests, troponin assays, and other immunoassay-based lab tests - always inform your clinician if taking biotin. This is listed as a clinical concern in dermatology textbook treatment considerations (Dermatology 5e, Elsevier).